Abstract 1681: RenLite® transgenic mice provide a high-quality platform for accelerating the development of fully human bispecific antibodies or ADCs worldwide
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148864268
